Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia

Significant advances in our understanding of the genetic defects and the pathogenesis of juvenile myelomonocytic leukemia (JMML) have been achieved in the last several years. The information gathered tremendously helps us in designing molecular targeted therapies for this otherwise fatal disease. Va...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoling, Sabnis, Himalee, Bunting, Kevin D., Qu, Cheng-Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226315/
https://www.ncbi.nlm.nih.gov/pubmed/22162691
http://dx.doi.org/10.1155/2012/308252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226315/
https://www.ncbi.nlm.nih.gov/pubmed/22162691
http://dx.doi.org/10.1155/2012/308252

Ejemplares similares